The present invention relates to a hepcidin antagonist for use in the treatment of inflammatory diseases. TLR4-dependant intestinal hepcidin induces […]
The present invention relates to the treatment of microbiome dysregulations. Said dysregulations may subsequently contribute to the development of […]
There is an interest to develop anti-ROBO4 antibodies that can be suitable for the treatment of cancer. The inventors produced new human antibodies […]
In ovarian carcinoma, Müllerian Inhibiting Substance (MIS) type II receptor (MISRII) and the MIS/MISRII signaling pathway are potential therapeutic […]
The present invention relates to a virus-derived particle comprising one or more Cas protein(s), as well as to kits and methods using the same for […]
The invention relates to peptides derived from the MELOE antigen for therapeutic vaccination against cancer. A phase I clinical trial for ex-vivo […]
The present invention relates to methods and pharmaceutical compositions for the treatment of Erythropoietic Protoporphyria. In particular, the […]
The present invention concerns an oligonucleotide modified by substitution at the 3’ or the 5’ end by at least triple alkyl chain or at least one […]
The present invention relates to a method for treating an infection, particularly HCMV infection. To date, there are very few reports on the role of […]
The present invention relates to methods for adhering tissue surfaces and materials and biomedical uses thereof. In particular the present invention […]